Psychopharmacology

Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats
pp. 857-865(9)
Authors: Saitoh, Akiyoshi; Yamaguchi, Kazumasa; Tatsumi, Yoshimi; Murasawa, Hiroyasu; Nakatani, Akiko; Hirose, Noritaka; Yamada, Misa; Yamada, Mitsuhiko; Kamei, Junzo

Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats
pp. 867-877(11)
Authors: Schramm-Sapyta, Nicole; Cha, Young; Chaudhry, Saba; Wilson, Wilkie; Swartzwelder, H.; Kuhn, Cynthia

Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition
pp. 879-889(11)
Authors: Szczytkowski, Jennifer; Lysle, Donald

Nicotine increases FosB expression within a subset of reward- and memory-related brain regions during both peri- and post-adolescence
pp. 891-897(7)
Authors: Soderstrom, Ken; Qin, Weixi; Williams, Helen; Taylor, David; McMillen, Brian

The effects of a single session of inescapable tailshock on the subsequent locomotor response to brief footshock and cocaine administration in rats
pp. 899-907(9)
Authors: Der-Avakian, Andre; Rozeske, Robert; Bland, Sondra; Watkins, Linda; Maier, Steven

The effects of a single exposure to uncontrollable stress on the subsequent conditioned place preference responses to oxycodone, cocaine, and ethanol in rats
pp. 909-917(9)
Authors: Der-Avakian, Andre; Bland, Sondra; Rozeske, Robert; Tamblyn, Julie; Hutchinson, Mark; Watkins, Linda; Maier, Steven

Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers
pp. 919-929(11)
Authors: Dunbar, G.; Boeijinga, P.; Demazières, A.; Cisterni, C.; Kuchibhatla, R.; Wesnes, K.; Luthringer, R.

The effects of buprenorphine on fentanyl withdrawal in rats
pp. 931-941(11)
Authors: Bruijnzeel, Adrie; Marcinkiewcz, Catherine; Isaac, Shani; Booth, Matthew; Dennis, Donn; Gold, Mark

A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers
pp. 943-950(8)
Authors: Paterson, Louise; Wilson, Sue; Nutt, David; Hutson, Peter; Ivarsson, Magnus

Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg
pp. 951-959(9)
Authors: Leufkens, Tim; Vermeeren, Annemiek; Smink, Beitske; Ruitenbeek, Peter; Ramaekers, Johannes

The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats
pp. 961-974(14)
Authors: Ma, Jingyi; Leung, L.

Tiagabine does not attenuate alcohol-induced activation of the human reward system
pp. 975-983(9)
Authors: Fehr, Christoph; Hohmann, Nina; Gründer, Gerhard; Dielentheis, Thomas; Buchholz, Hans-Georg; Chechko, Natalie; Yakushev, Igor; Landvogt, Christian; Bartenstein, Peter; Urban, Reinhard; Schreckenberger, Mathias

Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice
pp. 985-993(9)
Authors: Carrigan, Kelly; Dykstra, Linda

A pharmaco-EEG study on antipsychotic drugs in healthy volunteers
pp. 995-1004(10)
Authors: Yoshimura, Masafumi; Koenig, Thomas; Irisawa, Satoshi; Isotani, Toshiaki; Yamada, Keizo; Kikuchi, Mitsuru; Okugawa, Gaku; Yagyu, Takami; Kinoshita, Toshihiko; Strik, Werner; Dierks, Thomas

Changes in brain ¹¹C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET
pp. 1005-1014(10)
Authors: Kadir, Ahmadul; Darreh-Shori, Taher; Almkvist, Ove; Wall, Anders; Långström, Bengt; Nordberg, Agneta

Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study
pp. 1015-1022(8)
Authors: Novick, Diego; Haro, Josep; Suarez, David; Lambert, Martin; Lépine, Jean-Pierre; Naber, Dieter

Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up
pp. 1023-1026(4)
Authors: Nickel, Marius; Loew, Thomas; Gil, Francisco

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial
pp. 1027-1029(3)
Authors: Naber, Dieter; Greenspan, Andrew; Schreiner, Andreas